glp-1 supply chain news The Ozempic Effect: How Drugs Are Transforming U.S. Food & Beverage and Pharma Logistics News Bites: Global Supply Chain

You can find more here.

Healthy weight loss should not be fast, she says

Protein intake drops disproportionately

See if You Qualify The Ozempic Lawsuit is an active lawsuit See If You Qualify Ozempic and Gastroparesis Overview Litigation is pending against Novo Nordisk, the manufacturer of Ozempic, for allegedly not properly warning about the potentially severe gastrointestinal side effects related to its GLP-1 drugs

Another study, the EXAMINE trial, investigated alogliptin medication in individuals with Type 2 diabetes who had experienced acute coronary syndrome and revealed no increase in major adverse cardiovascular events

NICE recommends GLP-1 receptor agonists for type 2 diabetes when metformin and other oral medications fail to achieve adequate glycaemic control, particularly with BMI 35 kg/m or weight-related comorbidities